BILITE: a Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacy (Q6617390)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: BILITE: a Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacy |
scientific article; zbMATH DE number 7924899
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BILITE: a Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacy |
scientific article; zbMATH DE number 7924899 |
Statements
BILITE: a Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacy (English)
0 references
10 October 2024
0 references
Bayesian adaptive design
0 references
cure models
0 references
immunotherapy
0 references
longitudinal immune response
0 references
0 references
0 references
0 references
0 references
